Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 301–400 of 1,004
Millanes‐Romero, A., Herranz, N., Perrera, V., Iturbide, A., Loubat‐Casanovas, J., Gil, J., Jenuwein, T., de Herreros, A. G., & Peiró, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.015 · Cited by 126
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas
Yue, D., Li, H., Che, J., Zhang, Y., Tseng, H.-H. K., Jin, J. Q., Luh, T. M., Leprieur, E. G., Mo, M., Zheng, Q., et al. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-34 · Cited by 112
Ju, J., Chen, A., Deng, Y., Liu, M., Wang, Y., Wang, Y., Nie, M., Wang, C., Ding, H., Yao, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00988-5 · Cited by 105
Extracellular matrix density promotes EMT by weakening cell–cell adhesions
Kumar, S., Das, A., & Sen, S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70431a · Cited by 114
Boudreau, H. E., Casterline, B. W., Burke, D. J., & Leto, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.165 · Cited by 107
“During tumour progression, transformed cells become unresponsive to the tumour-suppressive effects of TGF-b and respond with tumour-promoting effects by undergoing changes in morphology leading to increasing cell mobility, invasion, and metastasis (Xu et al, 2009; De Craene and Berx, 2013).”
BackgroundL1 retrotransposons, cancer stem cells and oncogenesis
Carreira, P. E., Richardson, S. R., & Faulkner, G. J. (2014) · The FEBS Journal · doi:10.1111/febs.12601 · Cited by 101
Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention
Jafri, M., Al-Qahtani, M. H., & Shay, J. W. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.004 · Cited by 106
“DTCs in their supportive niches initiate an EMT reverse rogram called mesenchymal-to-epithelial transition (MET) that avors colonization [146].”
BackgroundXie, F., Zhou, X., Li, H., Su, P., Liu, S., Li, R., Zou, J., Xiang, W. D., Pan, C., Zhang, Z., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108791 · Cited by 119
“TGF-b stimulates the epithelial-to-mesenchymal transition (EMT), migration, invasion, and metastasis of breast cancer cells (Brabletz, 2012; Burgess, 2013; De Craene & Berx, 2013).”
The Role of MicroRNAs in Chemoresistance
Bahreini, F., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_336-1 · Cited by 100
Nowrin, K., Sohal, S. S., Peterson, G. M., Patel, R. P., & Walters, E. H. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.948853 · Cited by 106
“In non-small-cell lung cancer, active EMT is associated with the formation of cancer stem cells [23], drug resistance and epidermal growth factor receptor mutations [27].”
Role of ATP-binding cassette transporters in cancer initiation and progression
Nobili, S., Lapucci, A., Landini, I., Coronnello, M., Roviello, G., & Mini, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.006 · Cited by 97
Tang, Q., Li, W., Zheng, X., Ren, L., Liu, J., Li, S., Wang, J., & Du, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00288-3 · Cited by 112
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review
Sheikh, E., Tran, T. T., Vranić, S., Levy, A., & Bonfil, R. D. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.7399 · Cited by 147
“Different studies have shown that the expression of EMT transcription factors is also increased in CSCs [147,149,150], and a growing body of evidence supports the view that circulating tumor cells (CTCs) can arise from tumor cells that have gone through EMT [151-154].”
InfluentialEpigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor–Resistant Cutaneous Melanomas
Wang, J., Huang, S. K., Marzese, D. M., Hsu, S. C., Kawas, N. P., Chong, K. K., Long, G. V., Menzies, A. M., Scolyer, R. A., Izraely, S., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.418 · Cited by 111
“Melanoma, a tumor of neuroectodermal origin, can display epithelial to mesenchymal transition (EMT), which is a complex process associated with invasion and metastasis of various types of solid tumors (Craene and Berx, 2013; Kudo-Saito et al. , 2009; Weiss et al. , 2012).”
The multiverse nature of epithelial to mesenchymal transition
Simeone, P., Trerotola, M., Franck, J., Cardon, T., Marchisio, M., Fournier, I., Salzet, M., Maffia, M., & Vergara, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.004 · Cited by 98
Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
Zhou, Y., Zhang, X., & Klibanski, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.006 · Cited by 104
“It is one of the major factors inhibiting epithelial–mesenchymal transition (EMT), which converts epithelial cells to migratory and invasive cells (De Craene and Berx, 2013).”
BackgroundProbing the Fifty Shades of EMT in Metastasis
Li, W., & Kang, Y. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.01.001 · Cited by 97
“EMT, which can be triggered by multiple mechanisms, is orchestrated by a complex network of transcription factors, epigenetic regulators and noncoding RNAs [8] (Figure 1).”
BackgroundLung cancer stem cell markers as therapeutic targets: An update on signaling pathways and therapies
Zheng, Y., Wang, L., Yin, L., Yao, Z., Tong, R., Xue, J., & Lu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873994 · Cited by 97
“The HH and Wnt pathways can jointly induce CSC biomarkers, such as CD44, CD133, BMI1, and LGR5, and promote EMT, thereby promoting tumor cell infiltration and distant metastasis and allowing tumor cells to obtain stem cell characteristics and drug resistance capacity (74).”
BackgroundZhou, Y., Liang, C., Xue, F., Chen, W., Zhi, X., Feng, X., Bai, X., & Liang, T. (2015) · Oncotarget · doi:10.18632/oncotarget.3585 · Cited by 107
“Epithelial to mesenchymal transition (EMT), a biological process during which polarized epithelial cells transform into motile mesenchymal cells, plays important roles in many processes during the progression of malignant tumors, including proliferation, invasion and migration [10].”
Brozovic, A., Duran, G. E., Wang, Y. C., Francisco, E. B., & Sikic, B. I. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.015 · Cited by 98
Kondaveeti, Y., Reed, I. K. G., & White, B. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.025 · Cited by 111
“These changes constitute the epithelial–mesenchymal transition (EMT), a process that is orchestrated by the re-expression of embryonic transcription factors, including ZEB1, ZEB2, SLUG and SNAIL, in response to genetic damage coupled to multiple signals within the microenvironment, including the hormone/growth factors…”
BackgroundCheng, X., Lu, X.-X., Guo, P.-D., Shen, T., Zhang, S., He, X., Gan, W.-J., Li, X., Wang, J., Zhao, Y., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3595 · Cited by 104
“USP4 induces PRL-3–dependent Akt activation and E-cadherin loss Dysregulation of PI3K/Akt signaling pathways and other key events, such as the EMT, is associated with cancer development (32, 33).”
BackgroundWu, Z.-H., Tao, Z., Zhang, J., Li, T., Chen, N., Xie, J., Zhang, J., & Hu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4604-7 · Cited by 103
Bourcy, M., Suarez‐Carmona, M., Lambert, J., Francart, M., Schroeder, H., Delierneux, C., Skrypek, N., Thompson, E. W., Jérusalem, G., Berx, G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2263 · Cited by 103
Self-citationYoshida, T., Song, L., Bai, Y., Kinose, F., Li, J., Ohaegbulam, K. C., Muñoz-Antonia, T., Qu, X., Eschrich, S., Uramoto, H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147344 · Cited by 96
“EMT is essential for tumor invasion, metastasis, and drug resistance in many cancers [29] [16,22,52].”
BackgroundZhang, Y.-Y., Kong, L., Zhu, X.-D., Cai, H., Wang, C.-H., Shi, W.-K., Cao, M.-Q., Li, X., Li, K.-S., Zhang, S.-Z., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.004 · Cited by 96
Cevenini, A., Orrù, S., Mancini, A., Alfieri, A., Buono, P., & Imperlini, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082411 · Cited by 95
“These factors often influence the expression of each other, frequently converge in the regulation of common target genes and in general upregulate mesenchymal genes and repress epithelial genes [6,120,121,133,134].”
BackgroundTang, Y., Durand, S., Dalle, S., & Caramel, J. (2020) · Cancers · doi:10.3390/cancers12082154 · Cited by 122
“Regulated by microenvironmental signals, this cellular plasticity process is driven by a network of embryonic EMT-inducing transcription factors (EMT-TFs) mainly represented by the SNAIL, TWIST, and ZEB protein families, which interact with epigenetic regulators [2,3].”
BackgroundOTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability
Zhou, H., Liu, Y., Zhu, R., Ding, F., Cao, X., Lin, D., & Liu, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0224-1 · Cited by 95
Cell Volume Regulation in Epithelial Physiology and Cancer
Pedersen, S. F., Hoffmann, E. K., & Novak, I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00233 · Cited by 94
“Markers of the full-blown EMT include up-regulation of α -smooth muscle actin ( α -SMA), vimentin, and fibronectin, and down-regulation of epithelial markers such as E-cadherin, cytokeratins, and the tight junction protein ZO-1 (Kalluri and Weinberg, 2009; Nelson, 2009; De Craene and Berx, 2013).”
BackgroundYe, Z., Zhou, M., Tian, B., Wu, B., & Li, J. (2015) · Europe PMC (PubMed Central) · Cited by 94
Epithelial to Mesenchymal Transition in a Clinical Perspective
Pasquier, J., Abu-Kaoud, N., Thani, H. A., & Rafii, A. (2015) · Journal of Oncology · doi:10.1155/2015/792182 · Cited by 102
Schulenburg, A., Blatt, K., Cerny‐Reiterer, S., Sadovnik, I., Herrmann, H., Marian, B., Grunt, T. W., Zielinski, C. C., & Valent, P. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0113-9 · Cited by 98
“In epithelial tumors, CSC redistribution is facilitated by the socalled epithelial-mesenchymal transition (EMT), a process that is associated with a loss of specific (adhesive) interactions between cancer cells and the surrounding microenvironment [233,244,245].”
BackgroundGao, T., Li, J.-Z., Lü, Y., Zhang, C., Li, Q., Mao, J., & Li, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.02.044 · Cited by 100
Chen, J., Ji, T., Wu, D., Shi, J., Zhao, J., Lin, H. M., & Cai, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1622-1 · Cited by 101
Ma, M., Xu, H., Liu, G., Wu, J., Li, C., Wang, X., Zhang, S., Xu, H., Ju, S., Wei, C., et al. (2019) · Hepatology · doi:10.1002/hep.30602 · Cited by 94
Clinical Evolution of Epithelial–Mesenchymal Transition in Human Carcinomas
Navas, T. A., Kinders, R. J., Lawrence, S. M., Ferry‐Galow, K. V., Borgel, S. D., Hollingshead, M. G., Srivastava, A. K., Alcoser, S. Y., Makhlouf, H. R., Chuaqui, R. F., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3539 · Cited by 99
“Because transcriptional control of EMT is complex and is regulated by a wide array of transcription factors, includingNANOG (3, 39, 41, 42), andmicroRNAs (16, 43), the measurement of downstream protein markers of epithelial and mesenchymal expression programs (E-cadherin and vimentin) was our preferred strategy for di…”
BackgroundMethodAKT-ions with a TWIST between EMT and MET
Tang, H., Massi, D., Hemmings, B. A., Mandalà, M., Hu, Z., WICKI, A. N., & Xue, G. (2016) · Oncotarget · doi:10.18632/oncotarget.11232 · Cited by 95
“Mechanistically, Twist-promoted cancer metastasis is mediated through its transcription activity that is hijacked by cancer cells [25].”
BackgroundThe biology, function and clinical implications of exosomes in lung cancer
Zhou, L. Q., Lv, T., Zhang, Q., Zhu, Q., Zhan, P., Zhu, S., Zhang, J., & Song, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.003 · Cited by 97
Chi, H., Tsai, C., Tsai, M.-M., Yeh, C., & Lin, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091903 · Cited by 101
“Activation of epithelial–mesenchymal transition (EMT) is considered necessary to allow epithelial cancer cells local invasion and dissemination at distant organs [10,11].”
BackgroundShi, D., Wu, F., Mu, S., Hu, B., Zhong, B., Gao, F., Qing, X., Liu, J., Zhang, Z., & Shao, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1363-0 · Cited by 99
“Loss of epithelial phenotype and the acquisition of mesenchymal properties are essential characteristics of EMT [8, 11].”
BackgroundSchaeffer, D., Somarelli, J. A., Hanna, G., Palmer, G. M., & García-Blanco, M. A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00694-14 · Cited by 97
“EMT is a normal program observed in mesoderm development and neural crest formation (6) as well as wound healing (7); however, carcinoma cells can coopt this series of biological processes to initiate the metastatic cascade (8).”
BackgroundCheng, F., Su, L., Yao, C., Liu, L., Shen, J., Liu, C., Chen, X., Luo, Y., Jiang, L., Shan, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.010 · Cited by 92
A Review on Annona muricata and Its Anticancer Activity
Ilango, S., Sahoo, D. K., Paital, B., Kathirvel, K., Gabriel, J. I., Subramaniam, K., Jayachandran, P., Dash, R. K., Hati, A. K., Behera, T. R., et al. (2022) · Cancers · doi:10.3390/cancers14184539 · Cited by 91
Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 102
“A mechanistic link between EMT and radiation response signaling is that ZEB1 is phosphorylated and stabilized by ATM in response to DNA damage.”
BackgroundAutophagy as a Potential Therapy for Malignant Glioma
Escamilla-Ramírez, Á., Castillo‐Rodríguez, R. A., Zavala-Vega, S., Jiménez‐Farfán, D., Anaya‐Rubio, I., Briseño, E., Palencia, G., Guevara, P., Cruz-Salgado, A., Sotelo, J., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13070156 · Cited by 97
TRIM29 Suppresses TWIST1 and Invasive Breast Cancer Behavior
Ai, L., Kim, W.-J., Alpay, M., Tang, M., Pardo, C. E., Hatakeyama, S., May, W. S., Kladde, M. P., Heldermon, C. D., Siegel, E. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3579 · Cited by 95
“Such alterations in gene expression are governed, in part, by a set of basic helix-loop-helix (bHLH) transcription factors that promote acquisition of motile and invasive behavior (29).”
BackgroundEpithelial Mesenchymal Transition in Aggressive Lung Cancers
Mittal, V. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_3 · Cited by 106
Feng, M., Feng, J., Chen, W., Wang, W., Wu, X., Zhang, J., Xu, F., & Lai, M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0564-9 · Cited by 93
“During cancer progression, EMT contributes to invasiveness [22].”
Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters
Bithi, S. S., & Vanapalli, S. A. (2017) · Scientific Reports · doi:10.1038/srep41707 · Cited by 96
Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance
Videira, M., Reis, R. L., & Brito, M. A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.011 · Cited by 106
“In tumor cells, the absence of these proteins together with the expression of mesenchymal markers, such as vimentin and fibronectin, is associated with morphological changes correlated with the cell EMT being therefore considered hallmarks usually correlated with tumor migration, invasiveness and metastasization [73–7…”
BackgroundLi, G., Wang, W. T., Sun, J., Xin, B., Zhang, X., Wang, T., Zhang, Q.-F., Yao, L.-B., Han, H., Fan, D., et al. (2018) · Theranostics · doi:10.7150/thno.23463 · Cited by 93
“The expression of these key transcription factors is tightly regulated at different steps of transcription, translation and protein stability control by a variety of cell-intrinsic pathways as well as extracellular cues[5].”
BackgroundRecent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Sun, X., Zhao, P., Lin, J., Chen, K., & Shen, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.16 · Cited by 96
“In another case of a patient with non-small cell lung cancer, the drug-resistant cells metastasized into neuroendocrine cells([49]).”
BackgroundKhalili‐Tanha, G., Radisky, E. S., Radisky, D. C., & Shoari, A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06447-w · Cited by 112
“Type 3 EMT arises in epithelial tumor cells through genetic and epigenetic alterations that promote malignant transformation and progression [140, 141].”
Balachander, G. M., Andugulapati, S. B., Rangarajan, A., & Chatterjee, K. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b09064 · Cited by 96
Kurashige, J., Mima, K., Sawada, G., Takahashi, Y., Eguchi, H., Sugimachi, K., Mori, M., Yanagihara, K., Yashiro, M., Hirakawa, K., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu232 · Cited by 89
Zhao, Y., Tang, H., Zeng, X., Ye, D., & Liu, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.029 · Cited by 89
An emerging tumor invasion mechanism about the collective cell migration.
Yang, Y., Zheng, H., Zhan, Y., & Fan, S. (2019) · PubMed · Cited by 115
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
Hossain, S. M., & Eccles, M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021601 · Cited by 101
Sabouni, E., Nejad, M. M., Mojtabavi, S., Khoshdooz, S., Mojtabavi, M., Nadafzadeh, N., Nikpanjeh, N., Mirzaei, S., Hashemi, M., Aref, A. R., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114395 · Cited by 99
Canesin, G., Cuevas, E. P., Santos, V., López‐Menéndez, C., Moreno‐Bueno, G., Huang, Y., Csiszár, K., Portillo, F., Peinado, H., Lyden, D. C., et al. (2014) · Oncogene · doi:10.1038/onc.2014.23 · Cited by 97
Lu, M., Yang, L., Li, R., Rodrigues, D. N., Crespo, M., Hsieh, J., Tilley, W. D., Bono, J. S. D., Selth, L. A., & Raj, G. V. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2169 · Cited by 95
Zhao, F. H., Wang, M., Li, S., Bai, X., Bi, H.-L., Liu, Y., Ao, X., Jia, Z., & Wu, H. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.3 · Cited by 91
Xu, M., Zhu, C., Zhao, X., Chen, C., Zhang, H., Yuan, H., Deng, R., Dou, J., Wang, Y., Huang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2825 · Cited by 88
“In the past few decades, many scientists in the world have focused on the core EMT-TFs and their regulatory networks during cancer initiation and progression [11, 53], however, the underlying mechanisms have not been fully elucidated.”
BackgroundVandamme, N., Denecker, G., Bruneel, K., Blancke, G., Akay, Ö., Taminau, J., Coninck, J. D., Smedt, E. D., Skrypek, N., Loocke, W. V., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2373 · Cited by 103
Self-citationHuang, H., Huang, F., Liang, X., Fu, Y., Cheng, Z., Huang, Y., Chen, Z., Duan, Y., & Chen, Y. (2022) · Pharmaceuticals · doi:10.3390/ph16010037 · Cited by 97
Jin, Y., Shenoy, A. K., Doernberg, S. N., Chen, H., Luo, H., Shen, H., Lin, T., Tarrash, M., Cai, Q., Hu, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.037 · Cited by 89
“Therefore, the FBXO11-Snai1 interaction is independent of GSK3βmediated phosphorylation, and thus differs from the FBXW1-Snai1 association.”
BackgroundInfluentialWu, S., Lin, W., Shen, C., Pan, H., Keh‐Bin, W., Chen, Y., Jan, Y., Lai, D., Tang, S., Tien, H., et al. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12295 · Cited by 87
“Downregulation of E-cadherin expression or dephosphorylation of E-cadherin in cancer cells is a decisive disruptor of epithelial homeostasis, increased tumor formation, and augmenting tissue invasiveness [9].”
BackgroundDai, X., Ahn, K. S., Wang, L. Z., Kim, C., Deivasigamni, A., Arfuso, F., Um, J., Kumar, A. P., Chang, Y., Kumar, D., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0391 · Cited by 88
“Involvement of Snail/Slug in ASC-mediated reversal of EMT in hepatocellular carcinoma cells Transcriptional repressors of E-cadherin, such as zinc finger proteins (ZEB1, ZEB2), bHLH protein (Twist), and the SNAIL family of zinc finger proteins (Snail, Slug), have been reported to be involved in EMT process and can dir…”
BackgroundLiquid biopsy for lung cancers: an update on recent developments
Revelo, A. E., Martin, A., Velasquez, R., Kulandaisamy, P. C., Bustamante, J., Keshishyan, S., & Otterson, G. A. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.03.28 · Cited by 92
“Epithelial tumor cells typically undergo a complex process known as epithelial-mesenchymal transition (EMT), where a cascade of signals enable these cells to enter the circulation and reach a remote target, where they will later undergo a reverse process called mesenchymal to epithelial transition (MET).”
BackgroundInfluentialPicard, F. S. R., Lutz, V., Brichkina, A. I., Neuhaus, F., Ruckenbrod, T., Hupfer, A., Raifer, H., Klein, M., Bopp, T., Pfefferle, P. I., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327855 · Cited by 94
Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma
Perrot, C. Y., Javelaud, D., & Mauviel, A. (2013) · Annals of Dermatology · doi:10.5021/ad.2013.25.2.135 · Cited by 101
SURVIV for survival analysis of mRNA isoform variation
Shen, S., Wang, Y., Wang, C., Wu, Y. N., & Xing, Y. (2016) · Nature Communications · doi:10.1038/ncomms11548 · Cited by 95
Tong, Y., Yang, H.-Y., Xu, X., Ruan, J., Liang, M., Wu, J., & Luo, B. (2017) · Cancer Science · doi:10.1111/cas.13191 · Cited by 85
The biology and clinical potential of circulating tumor cells
Ložar, T., Geršak, K., Čemažar, M., Kuhar, C. G., & Jesenko, T. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0024 · Cited by 97
Shetti, D., Zhang, B., Fan, C., Mo, C., Lee, B. H., & Wei, K. (2019) · Cells · doi:10.3390/cells8080892 · Cited by 85
“MMPs help in the degradation of the extracellular matrix (ECM) and allow tumors to lose their epithelial characteristics and to acquire mesenchymal phenotypes that are highly regulated by transcriptional factors such as Zeb1, Slug, Snail, TGF-β, and Twist [32,33].”
BackgroundKaur, J., Sawhney, M., DATTAGUPTA, S., Shukla, N. K., Srivastava, A., Walfish, P. G., & Ralhan, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067361 · Cited by 85
Recent advances in pancreatic cancer: biology, treatment, and prevention
Singh, D. K., Upadhyay, G., Srivastava, R. K., & Shankar, S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.04.003 · Cited by 93
“It is remarkable that during the EMT process, epithelial cells gain the mesenchymal over endothelial characteristic thereby increasing in migratory and invasive capacity, leading to invasion and metastasis [77,78].”
BackgroundYu, G., Jia, Z., & Dou, Z. (2016) · Oncology Reports · doi:10.3892/or.2016.5326 · Cited by 84
“Increasing evidence has shown that the epithelial-mesenchymal transition (EMT), a crucial development process, promotes cancer invasion and metastasis (24,25).”
RetractedHu, H., Wang, Y., Ding, X., He, Y. M., Lu, Z., Wu, P., Tian, L., Yuan, H., Liu, D., Shi, G., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0761-9 · Cited by 89
“Furthermore, EMT has been recognized as an important event in the initiation of cancer metastasis [29, 30], during which epithelial cells lose their apical-basal polarity and develop a mesenchymal phenotype.”
ZFAS1: a novel tumor-related long non-coding RNA
Dong, D. F., Mu, Z., Zhao, C., & Sun, M. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0623-y · Cited by 85
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Karagiannis, D., & Rampias, T. N. (2021) · Cancers · doi:10.3390/cancers13143575 · Cited by 95
Zhang, H., Zhang, G., Xu, P., Yu, F., Li, L., Huang, R., Zhang, Z., Kadier, K., Wang, Y., Gu, Q., et al. (2025) · Med Research · doi:10.1002/mdr2.70004 · Cited by 133
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma
Ho, T. H., Park, I. Y., Zhao, H., Tong, P., Champion, M. D., Yan, H., Monzon, F. A., Hoang, A., Tamboli, P., Parker, A. S., et al. (2016) · Oncogene · doi:10.1038/onc.2015.221 · Cited by 84
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 84
Dong, S., Kong, J., Kong, F., Kong, J., Gao, J., Ke, S., Wang, S., Ding, X., Sun, W., & Zheng, L. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-273 · Cited by 88
“Epithelial-mesenchymal transition (EMT) is a key process that drives cancer metastasis, and it is characterized by loss of the epithelial marker, increased expression of the mesenchymal marker, and enhanced migratory and invasive behaviors [13,14].”
Backgroundde‐Freitas‐Junior, J. C. M., & Morgado‐Díaz, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.6283 · Cited by 95
“Carcinoma progression involves the loss of cellcell adhesion and the acquisition of migratory and invasive potentials [29].”
BackgroundDa, C.-L., Liu, Y., Zhan, Y., Liu, K., & Wang, R. (2016) · Oncology Reports · doi:10.3892/or.2016.4661 · Cited by 84
“EMT transcription factors stimulate MMP expression, leading to an increase in MMPs, which further activates EMT transcription factors in a feed-forward loop (27).”
BackgroundShi, D., Wu, F., Mu, S., Hu, B., Zhong, B., Gao, F., Qing, X., Liu, J., Zhang, Z., & Shao, Z. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01574-2 · Cited by 85
Cancer stem cells and epithelial‐mesenchymal transition: Novel therapeutic targets for cancer
Ishiwata, T. (2016) · Pathology International · doi:10.1111/pin.12447 · Cited by 84
Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET
Jia, Y., Vong, J. S. L., Asafova, A., Garvalov, B. K., Caputo, L., Cordero, J., Singh, A., Boettger, T., Günther, S., Fink, L., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181394 · Cited by 86
Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis
Su, C., Chang, Y., Chien, M., Hsieh, Y., Chen, M.-K., Lin, C., & Yang, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2016-0 · Cited by 83
Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion
Mullins, R. D. Z., Pal, A., Barrett, T. F., Neal, M. E. H., & Puram, S. V. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4370 · Cited by 92
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
A miRNA signature associated with human metastatic medullary thyroid carcinoma
Santarpia, L., Călin, G. A., Adam, L., Ye, L., Fusco, A., Giunti, S., Christina Thaller, B., Paladini, L., Zhang, X., Jiménez, C., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0357 · Cited by 89
Zhang, K., Liu, P., Tang, H., Xie, X., Kong, Y., Song, C., Qiu, X., & Xiao, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01248 · Cited by 85
“Previous studies also indicated that the Wnt/β-catenin signaling pathway could enhance breast cancer invasion and metastasis (Dey et al., 2013; Li Y. et al., 2016; Tang et al., 2018).”
BackgroundRetractedShaurova, T., Zhang, L., Goodrich, D. W., & Hershberger, P. A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00281 · Cited by 89
Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
Fan, Y., Sun, Q., Li, X., Feng, J., Ao, Z., Li, X., & Wang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.718834 · Cited by 89
“EMT can be activated not only by a variety of signaling pathways such as TGF-β, EGF, miRNA, AKT, and PI3K but also by changes in ECM stiffness and endogenous mechanical stress (De Craene and Berx, 2013).”
BackgroundDhillon, A. S., & Tulchinsky, E. M. (2014) · Oncogene · doi:10.1038/onc.2014.374 · Cited by 87
Snail nuclear transport: The gateways regulating epithelial-to-mesenchymal transition?
Muqbil, I., Wu, J., Aboukameel, A., Mohammad, R. M., & Azmi, A. S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.003 · Cited by 82
“A number of different parallel signaling pathways interact in the development of EMT [2].”
Background
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.